Elevar Equity is a venture capital firm that invests early growth capital in businesses serving underserved customers and low-income communities in emerging markets, primarily India and Latin America. The firm focuses on sectors including financial services, healthcare, education, and agriculture.
50% of their portfolio is in Fintech. Average disclosed round size is $23.6M (across 13 rounds with reported amounts).
Portfolio
11
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 CureBay | Series B | $21M | Jan 2025 |
 Nia.one | Seed | $2.4M | Jan 2025 |
 TapFin | Seed | $4M | Mar 2024 |
 Cloudphysician | Unknown | $10.5M | Jan 2024 |
 SarvaGram | Series C | $35M | Jan 2023 |
| LLEAD School | Series C | $100M | Jan 2022 |
| SarvaGram | Series B | $10M | Jan 2021 |
| Cloudphysician | Series A | $4M | Jan 2021 |
 CreditMantri | Series B | $7.6M | Jan 2020 |
 Afluenta | Series B | $8M | Jan 2016 |
| SarvaGram | Series D | $67M | — |
 Niro | Series A | $11M | — |
 Bankingly | Series A | — | — |
| FFavo | Series A | $26.5M | — |
Top Co-Investors
India Quotient7 shared
Elevation Capital3 shared
Peak XV Partners3 shared
British International Investment2 shared
Bertelsmann India Investments1 shared
InnoVen Capital1 shared
Rebright Partners1 shared
Accion Ventures1 shared
Quona Capital1 shared
Endeavor1 shared
WestBridge Capital1 shared
GSV Ventures1 shared
H20 Capital Innovation1 shared
H20 Capital1 shared
Target Global1 shared
Tiger Global Management, LLC1 shared
FJ Labs1 shared
Last updated: 8 September 2026